SEC reporting owner

OrbiMed Israel BioFund GP Limited Partnership SEC insider disclosures

Reporting owner CIK0001569821
Issuers5
Qualifying disclosures28
Public purchases19
Recent-window purchases2
Recent-window sales4
Last public filing2026-04-10
Coverageverified

Issuer relationships

Recent SEC transactions

Publicly availableTrade dateTickerCodeSharesReported value
2026-04-092026-04-08ACETS40,416Not reported
2026-04-092026-04-08ACETS32,523Not reported
2026-04-092026-04-07ACETS2,400Not reported
2026-04-092026-04-07ACETS29,319Not reported
2025-10-102025-10-08ACETP3,500,000Not reported
2025-10-102025-10-08ACETP1,500,000Not reported

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page